滤泡性淋巴瘤患者接受利妥昔单抗治疗后血清阴性神经莱姆病的系列FDG PET/CT表现
一例60岁滤泡性淋巴瘤患者经6周期R-CHOP方案达完全缓解,末次注射利妥昔单抗2周后出现无热头痛、颈痛、手指感觉异常及左侧周围性面瘫。FDG PET/CT显示小脑和颈髓代谢增高,多西环素治疗3周后完全消退。此为中枢神经系统FDG PET/CT系列代谢变化的首例报道。
要点
- 利妥昔单抗治疗后的淋巴耗竭患者可出现血清阴性神经莱姆病
- FDG PET/CT可显示小脑和颈髓代谢增高,多西环素治疗后消退
- 血清学阴性时,脑脊液莱姆病螺旋体PCR检测有诊断价值
核心结论
- 本病例首次报道了神经莱姆病在中枢神经系统的系列FDG PET/CT代谢变化。
- 本病例说明利妥昔单抗治疗患者存在淋巴耗竭相关风险,并强调血清学阴性时脑脊液莱姆病螺旋体PCR检测的价值。
研究设计与样本
- 单个病例报告,患者为60岁男性滤泡性淋巴瘤,经6周期R-CHOP方案达完全缓解。
主要发现
- 末次利妥昔单抗注射2周后出现无热头痛、颈痛、手指感觉异常,后出现严重的左侧周围性面瘫。
- FDG PET/CT显示小脑和颈髓代谢增高,多西环素治疗3周后完全消退。
- 血清莱姆病抗体阴性,脑脊液莱姆病螺旋体PCR检测阳性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Published data concerning the semiology of neuroborreliosis at FDG PET/CT is scarce, and most reported cases with acute onset of neurological symptoms did not exhibit significant metabolic abnormalities. This 60-year-old man with follicular lymphoma achieved a complete response after 6 cycles of R-CHOP. Two weeks after the last injection, he developed afebrile headaches, neck pain, and paresthesia in his fingers, later followed by a brutal left peripheral facial palsy. FDG PET/CT demonstrated an increased metabolism of the cerebellum and of the cervical spinal cord, which completely resolved after treatment with doxycycline for 3 weeks. This is the first case report exhibiting serial metabolic changes at FDG PET/CT in the central nervous system during the evolution of the disease. This case illustrates the risks of lympho-depletion in patients treated with rituximab and highlights the value of PCR for Borrelia in the CSF in patients with false-negative Borrelia serology.
引用
- Drouet C, Guichard L, Durand A, et al. Serial FDG PET/CT Findings in a Patient With Seronegative Neuroborreliosis After Treatment With Rituximab for a Follicular Lymphoma. Clin Nucl Med. 2025. PMID: 40730480. doi:10.1097/RLU.0000000000006077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。